melanoma (skin)
Showing NaN - NaN of 37
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)
Completed
- Intraocular Melanoma
- +2 more
- melphalan
- +3 more
-
Santa Monica, California
- +11 more
Jun 15, 2021
Melanoma (Skin) Trial run by the CC (aldesleukin, filgrastim, incomplete Freund's adjuvant)
Completed
- Melanoma (Skin)
- aldesleukin
- +6 more
-
Bethesda, Maryland
- +1 more
Jun 30, 2017
Kidney Cancer, Melanoma (Skin), Metastatic Cancer Trial run by the CC (questionnaire administration, 3-dimensional conformal
Terminated
- Kidney Cancer
- +5 more
- questionnaire administration
- +4 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Nov 16, 2016
Melanoma (Skin) Trial run by the NCI (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)
Completed
- Melanoma (Skin)
- MART-1 antigen
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 29, 2015
Kidney Cancer, Melanoma (Skin) Trial run by the NCI (recombinant CD40-ligand, recombinant flt3 ligand)
Completed
- Kidney Cancer
- Melanoma (Skin)
- recombinant CD40-ligand
- recombinant flt3 ligand
-
Bethesda, MarylandSurgery Branch
Apr 29, 2015
Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, gp100 antigen)
Completed
- Melanoma (Skin)
- aldesleukin
- +2 more
-
Bethesda, MarylandSurgery Branch
Apr 28, 2015
Kidney Cancer, Melanoma (Skin) Trial run by the NCI (denileukin diftitox)
Completed
- Kidney Cancer
- Melanoma (Skin)
- denileukin diftitox
-
Bethesda, Maryland
- +1 more
Jun 18, 2013
Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- gp100 antigen
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)
Completed
- Melanoma (Skin)
- MART-1 antigen
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Colorectal Cancer, Endometrial Cancer, Head Neck Cancer Trial run by the NCI (aldesleukin, ras peptide cancer vaccine,
Completed
- Colorectal Cancer
- +8 more
- aldesleukin
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013
Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)
Completed
- Melanoma (Skin)
- MART-1 antigen
- +3 more
-
Bethesda, MarylandSurgery Branch
Jun 18, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, vaccinia-tyrosinase vaccine)
Completed
- Melanoma (Skin)
- aldesleukin
- +2 more
-
Bethesda, MarylandSurgery Branch
Jun 19, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, sargramostim)
Completed
- Melanoma (Skin)
- aldesleukin
- +4 more
-
Bethesda, MarylandSurgery Branch
Jun 19, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, gp209-2M antigen, incomplete Freund's adjuvant)
Completed
- Melanoma (Skin)
- aldesleukin
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, fowlpox virus vaccine vector, gp100 antigen)
Completed
- Melanoma (Skin)
- aldesleukin
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013
Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- aldesleukin
- ipilimumab
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Melanoma (Skin) Trial run by the NCI (NY-ESO-1 peptide vaccine, aldesleukin, filgrastim)
Completed
- Melanoma (Skin)
- NY-ESO-1 peptide vaccine
- +6 more
-
Bethesda, Maryland
- +1 more
Jun 18, 2013
Melanoma (Skin), Non-melanomatous Skin Cancer Trial run by the NIAMS (isotretinoin)
Completed
- Melanoma (Skin)
- Non-melanomatous Skin Cancer
-
Bethesda, MarylandIntramural Research Program
Jun 17, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, recombinant tyrosinase-related protein-2)
Completed
- Melanoma (Skin)
- aldesleukin
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 17, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, gp100 antigen, incomplete Freund's adjuvant)
Completed
- Melanoma (Skin)
- aldesleukin
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Melanoma (Skin) Trial run by the NCI (NY-ESO-1 peptide vaccine, aldesleukin)
Completed
- Melanoma (Skin)
- NY-ESO-1 peptide vaccine
- aldesleukin
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Melanoma (Skin) Trial run by the NCI (aldesleukin, recombinant fowlpox-tyrosinase vaccine, vaccinia-tyrosinase vaccine)
Completed
- Melanoma (Skin)
- aldesleukin
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)
Completed
- Melanoma (Skin)
- MART-1 antigen
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 17, 2013